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Abstract
The COVID-19 pandemic has the potential to cause high morbidity and mortality in crisis-affected populations.
Delivering COVID-19 treatment services in crisis settings will likely entail complex trade-offs between offering
services of clinical benefit and minimising risks of nosocomial infection, while allocating resources appropriately and
safeguarding other essential services. This paper outlines considerations for humanitarian actors planning COVID-19
treatment services where vaccination is not yet widely available. We suggest key decision-making considerations:
allocation of resources to COVID-19 treatment services and the design of clinical services should be based on
community preferences, likely opportunity costs, and a clearly articulated package of care across different health
system levels. Moreover, appropriate service planning requires information on the expected COVID-19 burden and
the resilience of the health system. We explore COVID-19 treatment service options at the patient level (diagnosis,
management, location and level of treatment) and measures to reduce nosocomial transmission (cohorting
patients, protecting healthcare workers). Lastly, we propose key indicators for monitoring COVID-19 health services.
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Background
The challenge of treating COVID-19 in humanitarian
responses
COVID-19 epidemics are resulting in high excess mor-
bidity and mortality across high-income countries. The
virus is expected to cause even more pernicious effects
in crisis-affected populations, defined here as forcibly
displaced people within or across national borders and
non-displaced persons affected by armed conflict, excep-
tional food insecurity and/or natural disasters, and in
need of humanitarian assistance. These populations may
face higher COVID-19 attack rates due to large house-
hold sizes, inadequate hygiene and access to safe water
and sanitation, and camp or urban overcrowding; they
may also experience higher disease severity and poorer
outcomes due to untreated co-morbidities and limited
access to health services [1].
COVID-19 treatment services may prove particularly
challenging in settings with low baseline healthcare cap-
acity, fragile supply chains and limited access to testing.
Aside from the complexities of adapting clinical proto-
cols to these conditions, humanitarian actors are likely
to face complex trade-offs when deciding whether and
which COVID-19 health services can be offered in a
given setting. In this paper, we outline considerations
and decision-making criteria for humanitarian and gov-
ernment actors to adapt routine health services and
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design COVID-19 health services. While the World
Health Organization (WHO) has published clinical man-
agement guidelines [2, 3] and ethical guidance for sup-
porting decision-making in outbreaks [4], we focus here
on supporting decision-makers in balancing resource al-
location across the spectrum of population healthcare
needs until vaccination is widely locally available.
Principles and objectives of COVID-19 treatment services
We suggest that the following principles should under-
pin decision-making and planning for provision of
COVID-19 health services:
▪ Beneficence: Care offered, particularly outside the
home and in settings where patients are separated
from their families, should offer an evidence-based
clinical benefit where available (including
documented, publicly-available clinical experience) to
the type of patient for whom it is intended – for
example, critical cases, severe but non-critical cases,
or non-severe with known risk factors [3].
Accordingly, COVID-19 inpatient facilities should
admit patients whose severity profile they are
equipped to mitigate, which will depend on resource
availability and expertise / experience (see Table 1).
The most experienced clinicians available should
make this assessment at triage;
▪ Non-maleficence: COVID-19 health services must
keep to a minimum the risk of nosocomial SARS-
CoV-2 infection for clinical and support staff.
Proposed COVID-19 treatment services should not be
pursued if this risk could (i) present staff with a
dilemma between caring for patients and preserving
their health, particularly when abstaining from care
provision would result in loss of income or stigma
[11]; (ii) cause unacceptable absenteeism, mortality or
long-term disability among healthcare workers,
particularly where such losses would leave serious,
long-term gaps in non-COVID-19 health service
delivery [12, 13]; and/or (iii) propagate transmission
within healthcare settings (e.g. to non-COVID-19
patients) to an extent likely to negate the clinical
benefits of treatment.
▪ Justice – efficiency: Against finite resources, COVID-
19 treatment services must be carefully balanced to
not excessively withdraw resources from potentially
more cost-effective interventions [14] to mitigate
both the direct effects of the epidemic (such as non-
pharmaceutical prevention) and its indirect effects
due to disruption of essential routine health services;
▪ Justice – equity of resource allocation: If COVID-19
treatment service capacity is not sufficient to meet
demand, it should be offered equitably, with priority
attributed to patients who would be most likely to
benefit from treatment or palliation. Corresponding
triage and admission criteria should be communicated
and understandable to the community;
▪ Justice – equity of access: COVID-19 health services
should be designed to proactively address barriers
to accessing care by those most in need and should
be accountable and acceptable to the catchment
population, with an emphasis on dialogue and
transparent communication.
In accordance with the above principles, we suggest
that COVID-19 health services in humanitarian re-
sponses should be designed to achieve all of the follow-
ing objectives:
1 Safeguard the delivery of essential non-COVID-19
health services;
2 Protect frontline healthcare and support workers
from infection;
3 Allocate resources optimally and equitably, while
minimising opportunity costs (e.g. diversion of
resources from more cost-effective interventions);
4 Reduce COVID-19 case-fatality and morbidity
through safe, dignified and effective COVID-19
health services including palliative care where
appropriate.
Decision-making and resource allocation
We propose a structured approach, coordinated across hu-
manitarian actors, local health authorities and communities,
to take decisions on which package of COVID-19 health
services is appropriate locally [15]. Factors for consideration
are summarised below. Figure 1 outlines an approach for
decision-making: in brief, we suggest that COVID-19 health
services at facility level (3 and 4 in Fig. 1) should only be
considered as a third priority, if resources are still available
after securing essential health services (1 in Fig. 1) and
enacting COVID-19 preventive measures within commu-
nity and home-based COVID-19 case management (2 in
Fig. 1).
Community preferences
Decisions on which COVID-19 health services to offer
should be accompanied by proactive, ongoing dialogue
with legitimate community members representing a
plurality of interests and perspectives [16, 17]. Humani-
tarian actors should communicate the rationale for re-
source allocation and changes to services; they should,
however, also be prepared to adapt blueprints to the
preferences of the local community (e.g. around burial,
end-of-life care or home- versus facility-based care for
severe cases, where oxygen is unavailable); or support
appropriate community innovations (e.g. around home
care). Community dialogue may also improve service
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design and utilisation (e.g. by identifying barriers to
accessing care).
Rational allocation of resources
Mitigating direct versus indirect morbidity and mortality
The economic trade-offs of mitigating the direct and in-
direct consequences of COVID-19 are complex and only
beginning to be quantified. While it may be rational to
withdraw resources from some routine health services to
scale up COVID-19 health services, emerging evidence
suggests that the pandemic could cause severe disrup-
tions to disease control programmes for tuberculosis,
HIV and malaria, causing indirect mortality on a scale
comparable to the epidemic itself [18], as noted during
the West Africa Ebola epidemic (2013–2016) [19], as
well to routine vaccination services [20]. Moreover,
when considering a metric of disability-adjusted life
years lost, the comparison between routine health ser-
vices (which disproportionately benefit younger age
groups) and COVID-19 care (benefiting older age
groups) is likely to favour the former even more than
crude mortality.
On balance, we believe therefore that preserving rou-
tine, essential health services is a more appropriate use
of limited resources than scaling up COVID-19 health
services to provide more intensive inpatient hospital care
(Table 1) [21]. Modelling studies suggest the benefits of
maintaining routine vaccination and tuberculosis ser-
vices during the pandemic far outweigh the risks of
nosocomial transmission of COVID-19 among people
seeking such routine services in health centres [22, 23].
Preserving the functionality and accessibility of a locally-
defined package of essential health services (e.g. inte-
grated management of childhood illness, management of
acute malnutrition, vaccination, family planning, ante-
natal care, management of obstetric and neonatal emer-
gencies, management of non-communicable diseases,
tuberculosis and HIV treatment, trauma surgery and
vector control) should thus take first priority in the pub-
lic health response to the pandemic. This includes pref-
erentially directing scarce Personal Protective
Equipment (PPE) supplies to these services, and not di-
verting core healthcare workers to COVID-19 health
services or triage, or to public health and surveillance
functions that can be fulfilled by non-clinical staff.
Prevention versus treatment
The opportunity costs of increasing COVID-19 health
services should also be considered in terms of foregoing
non-pharmaceutical interventions to reduce the epi-
demic’s impact, to the extent that the two sets of inter-
ventions may compete for the same financial, human
and material resources. Relatively cheap preventive mea-
sures such as behaviour change promotion [8], water,
hygiene and sanitation improvements, use of face masks,
and shielding of elderly or high-risk persons could
achieve considerable reductions in COVID-19 mortality
[24], and reduce pressure on health services. Conversely,
insufficient prevention would likely result in a demand
for hospitalisation capacity far in excess of even optimis-
tic scale-up assumptions [25].
Population- and patient-level prioritisation
When demand outstrips capacity, allocation of resources
must be based on equity, effectiveness and cost-
effectiveness considerations. At the population level, this
means geographically locating care closest to those most
vulnerable, e.g. communities with the least ability to
adopt COVID-19 preventive measures and/or the high-
est prevalence of known COVID-19 risk factors (e.g. un-
treated non-communicable diseases [3]). Conversely, at
the patient level, whilst considering community prefer-
ences, priority should be given to patients most likely to
benefit from care, as per explicit, transparent clinical
decision-making criteria based on prognostic indicators
and vulnerability scoring.
In extreme scenarios where capacity is insufficient
even for the highest-priority patient groups, decision
support frameworks similar to those used for mass cas-
ualty incidents and disaster response may need to be
temporarily applied [26] and should be re-evaluated fre-
quently. All patients should receive compassionate care
including symptomatic relief. Frameworks for these deci-
sions should be discussed with the community at the
early stages of the outbreak and, ideally, with other ac-
tors such as the Ministry of Health to ensure equity and
transparency.
Risks and minimum requirements for inpatient care
In most settings, short of a prolonged lockdown, model-
ling projections suggest that baseline hospitalisation cap-
acity may need to be increased by 10–1000 fold [27].
Designing COVID-19 health services accordingly re-
quires information on:
 Reasonable projections of peak expected caseload, by
severity (non-severe cases are also important for
planning, as they may greatly increase demand for
outpatient care). Scenarios should be conservative,
with the flexibility to be adjusted according to real-
time observations;
 Realistic capacity to scale up and sustain key inputs
including hospital infrastructure (e.g. electricity
supply, water, sanitation and hygiene), healthcare
workers (reallocation and training), treatment
supplies, and PPE [28]. The WHO has developed
tools to support resource quantification [29]; in
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particular, high volumes of oxygen are difficult to
ensure if only oxygen concentrators are available.
 Health service resilience, meaning its capacity to
adapt to meet the healthcare needs of the
population which requires dependable and adaptable
resources including supply chains, reliable funding
for healthcare, and reserve healthcare worker
capacity (loss of healthcare workers due COVID-19
infection or fear of acquiring the infection should be
expected during the epidemic) [30, 31].
Among rate-limiting factors, healthcare workers merit
special considerations. Advanced care for COVID-19 re-
quires high ratios of appropriately qualified and trained
clinicians to patients (this varies by setting and patient
profile e.g. 1:1 or 1:2 for nurses in UK critical care
settings [32]); when these ratios are diluted, risks of low-
quality care and harm to patients and healthcare workers
increase. At the community, triage or outpatient level,
additional capacity could be sourced by mobilising net-
works of allied health professionals (e.g. HIV or TB
community outreach), volunteers (e.g. Red Cross / Red
Crescent) and professionals from other sectors (e.g.
teachers). Psychological support for staff is imperative to
address trauma from capacity limitations or high case-
fatality, both of which may also increase the risks of at-
tacks on healthcare workers.
It is important to consider that the risks of providing
poor-quality care could be as great as the risks of not
providing care at all, either scenario leading to stigma-
tisation of local healthcare workers, community resist-
ance, deteriorating relations with beneficiaries, and
Fig. 1. Suggested decision-making flowchart to support decision-makers responding to the COVID-19 pandemic in humanitarian health settings
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morbidity and mortality from COVID-19 and other pre-
ventable deaths. The potential for harm to healthcare
workers due to COVID-19 should be an overriding
concern.
Planning COVID-19 treatment services
Table 1 summarises COVID-19 treatment service op-
tions that, given current evidence, are likely to provide
some clinical benefit and/or avert harm to patients, care-
givers and healthcare workers at each level of the health
system. Further details on diagnosis, assessing severity,
and management can be found in WHO guidance [3].
Considerations for service delivery
Location and level of care
Patients with mild COVID-19 symptoms and no risk
factors may experience equivalent and clinical benefits
from appropriate home care by family members. On bal-
ance, these benefits may outweigh risks posed by treat-
ment outside the home; for example, the risk of
nosocomial transmission, spending long periods away
from the family, and diversion of resources away from
other cost-effective interventions [5].
Experience from middle and high-income settings sug-
gests many severe cases require respiratory support [33],
while ventilated critical cases experience case-fatality ra-
tios > 50% [34, 35], against substantial care costs. Out-
patient and inpatient care in contexts that are unable to
offer even oxygen support are unlikely to offer an appre-
ciable clinical benefit for severe cases [36]: however,
since it is inevitable that patients will present, it is essen-
tial to plan care pathways even in these contexts.
On balance, therefore, we suggest that high coverage
of home care for COVID-19 should be prioritised first,
before allocating resources to supportive respiratory
care, expanding to intensive COVID-19 care for critical
cases only if lower care levels have been saturated in
terms of coverage and quality. Home care, however,
should be accompanied by careful messaging for non-
COVID-19 illness, so that patients, in particular children
and pregnant women, still seek prompt care: as dis-
cussed above, establishing triage and safe COVID-19
health services in routine health facilities would preserve
patient and provider confidence and is thus part and
parcel of a COVID-19 home care approach.
Test-confirmed versus syndromic diagnosis
Testing for SARS-CoV-2 infection is generally preferable
to syndromic management, if available. However, pa-
tients should receive timely and appropriate clinical care
while awaiting test results (as available, see Table 1). If
in short supply, tests should be preferentially reserved
for healthcare workers [37] and patients in whom a
SARS-CoV-2 test result would influence clinical man-
agement (i.e. by narrowing the differential diagnosis).
Where testing is not widely available (at the time of
writing, we believe this applies to most humanitarian
responses), syndromic management may be inevitable
[38]. This approach will however be complicated by
the overlap of signs and symptoms between COVID-
19 and other common diseases, including acute re-
spiratory infections (ARI) and malaria. The frequency
of presenting syndromes that fit both COVID-19 and
other illnesses as possible diagnoses will be greatest
as the COVID-19 epidemic peaks, in specific age
groups (e.g. children), geographic settings, or seasons
with a high background incidence of ARI and other
acute illnesses. It follows that syndromic case man-
agement of suspect COVID-19 cases will need to sim-
ultaneously combine:
1 A standard case definition, based on the latest
evidence available; and
2 Presumptive management of COVID-19, assuming
that the patient is indeed sick with COVID-19, as
per Table 1; and
3 Presumptive management of other possible
diagnoses, where possible ruling out diagnoses
through available diagnostics (e.g. rapid malaria
tests), and offering care for other illnesses as per
signs and symptoms. Syndromic case management
should holistically manage patients according to
their presentation, and not solely focus on COVID-
19; an overly vertical approach would likely result
in excess mortality due to untreated non-COVID-
19 health problems.
In Table 1, concurrent management of non-COVID-
19 syndromes is implied as a default option. Such case
management should follow local pre-pandemic service
specifications, with adaptations to reduce nosocomial
transmission of SARS-CoV-2 (see below).
Isolation without treatment
Simple isolation of cases in hospitalisation wards or
other structures, if no treatment is being offered, is likely
to have only a marginal effect on reducing transmission
(due to the large proportions of asymptomatic cases
[39]), could rapidly exceed capacity of available struc-
tures, would divert limited resources from more effective
interventions, may deter people from seeking healthcare,
and could put individuals at risk in conflict settings.
Self-isolation at home is likely to be more impactful and
acceptable [5]; as such we do not consider isolation
without treatment further in this paper as a valid
intervention.
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Table 1 Options for health services for confirmed or suspect COVID-19, by level of the health system
Level of care COVID-19 treatment services
objectives
Interventions
Home / community Promote safe and dignified home care
Reduce intra-household, community
and nosocomial transmission
• Promote home (and, if possible, self-) care of non-severe COVID-19
symptoms through supportive treatment (e.g. antipyretics) [5],
adequate hydration and nutrition. This can be supported through
community messaging and training of healthcare workers;
• Undertake risk communication and behaviour change promotion to
limit transmission within households and the wider community
(through patient home isolation and household self-quarantine),
and to make patients aware of when to seek higher levels of care
(e.g. for worsening symptoms);
• Identify people with risk factors for severe COVID-19, advising them
on care-seeking and promoting earlier supportive treatment if
COVID-19 symptoms occur (e.g. antipyretics) [5];
• Involve community health workers (CHWs) in COVID-19 treatment
service delivery, appropriate to their current workload and skillset,
as a secondary priority after COVID-19 risk communication and
behaviour change promotion [6]: CHW involvement may include
advice on home care, treatment seeking and self-isolation;
identification, monitoring and advice to people at high-risk of
severe COVID-19; support for home based palliative care [7] and
delivery of drugs and supplies to reduce patients’ need to visit
health facilities;
• Follow up for high-risk patients discharged from inpatient care
who could develop/ have developed complications (e.g. poor
nutritional status, respiratory difficulties).
Outpatient care Promote safe and dignified home care
Identify patients in need of
hospitalisation
• Encourage home care of non-severe cases, as above;
• Identify suspect COVID-19 patients with signs and symptoms of
severe illness and refer them onward if higher-level care is
available;
• Treat co-morbidities and co-infections, e.g. malaria, that may
be complicating the clinical picture;
• Identify people with risk factors for severe COVID-19 [3] and
assess presence of complications including hypoxia or
respiratory distress. Consider these patients for early hospital
admission (if appropriate and where available) e.g. to facilitate
monitoring and maintenance of oxygen levels. If they are well
but at high risk, consider monitoring them in the community
(if feasible and safe for CHWs) [6, 8];
• Follow up for high-risk patients discharged from inpatient
care who could develop/ have developed complications.
Inpatient (district hospital, in a
context where no respiratory
support, e.g. oxygen, is available)
Manage some COVID-19 complications
Identify patients in need of more
advanced care
If oxygen is not available, the risks of inpatient care are likely to
outweigh the benefits. However, worthwhile interventions may
include:
• Identify people with risk factors for severe COVID-19 [3] and
assess presence of complications including hypoxia, respiratory
distress, sepsis, dehydration, poor blood sugar control in
diabetics, hypertension, and co-infections; and manage
complications to the extent possible;
• Consider these patients for onward referral (if appropriate
and where available) to facilitate monitoring and maintenance
of oxygen levels and management of other complications;
• Offer palliative care if no further escalation of care is available
or appropriate [7].
Inpatient (more advanced care
including non-invasive respiratory
support)
Supportive care to improve clinical
outcomes
As above plus:
• Offer basic respiratory support (e.g. oxygen) as per COVID-19
clinical guidance [3];
• Offer other means of non-invasive ventilation, e.g. continuous
positive airway pressure [9] if its effectiveness is confirmed, and
with consideration for possible associated risk of nosocomial
transmission [10];




Intensive care to improve clinical
outcomes
As above plus:
• Manage critical cases through supportive measures including
invasive ventilation, cardiovascular support and renal supportive
care.
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Experimental therapy
The use of experimental therapy should be discouraged
except under clinical trial or monitored emergency use
conditions, as these may be ineffective or even harmful,
and can divert resources away from cost-effective inter-
ventions such as inpatient nutritional support or early
rehabilitation [3].
Palliative care
Palliative care may be delivered in the home or hospital
depending on bed capacity, cultural appropriateness, pa-
tient preference and availability of community health
services. Patients must receive compassionate, dignified
end-of-life care [3, 7]; high-intensity resources and
equipment should be reserved for patients more likely to
benefit clinically. Visitation by selected low-risk relatives
could be facilitated where possible, to not only support
psychosocial wellbeing but also potentially to provide
care; however these must be carefully balanced against
the risk of nosocomial spread and onward spread in the
community.
Preventing nosocomial transmission
Table 2 lists measures to reduce nosocomial transmis-
sion of SARS-CoV-2 in healthcare settings. In addition
to preventing infection, these measures are critical to
preserve caregiver and patient confidence in health ser-
vices. Figure 2 suggests a possible generic set-up for a
routine health facility to triage, separate and manage
suspected or test-confirmed COVID-19 and other
patients.
Risk assessment of healthcare workers
In addition to training and strict infection prevention
and control (IPC), morbidity and mortality among
healthcare workers is likely to be reduced if staff at high
risk of severe outcomes (e.g. those with co-morbidities)
are preferentially allocated to routine non-COVID-19
care; those who live with high-risk family members
should also either avoid direct COVID-19 care or be
supported to live separately from their household.
Cohorting COVID-19 patients
Separating patients with COVID-19 from other patients
will reduce nosocomial SARS-CoV-2 transmission, but
the effectiveness of cohorting depends on diagnostic ac-
curacy, itself a function of prevalence of true COVID-19
cases among presenting patients. Table 3 summarises
qualitatively the expected positive predictive value (PPV)
of COVID-19 diagnosis under alternative scenarios. If
testing is available, directing COVID-19 test-confirmed
patients to dedicated wards within hospitals, or to separ-
ate treatment facilities, will generally achieve clear
separation from other patients, as indicated by a high
positive predictive value of diagnosis.
By contrast, depending on the combination of
COVID-19 incidence and other diseases with overlap-
ping signs and symptoms, grouping together syndromi-
cally diagnosed COVID-19 patients is likely to expose
vulnerable non-COVID-19 patients and their caregivers
to nosocomial harm. To mitigate this risk, we suggest
cohorting by likelihood of COVID-19 diagnosis and by
risk profile [3], for example due to age or pregnancy sta-
tus. Syndromically diagnosed patients should be
cohorted by age (children should be cohorted separately)
and pregnancy status (particularly those in the third tri-
mester), whether in dedicated facilities or not, with re-
stricted movement between cohorts [41]; patients known
to have highly infectious co-morbidities, e.g. tubercu-
losis, should be treated separately.
Table 2 Measures to prevent SARS-CoV-2 nosocomial
transmission within healthcare settings
Health services:
• Communicate risk and treatment advice to the community, so as to
promote early recognition of symptoms by patients and their
caregivers, and informed decisions on whether and where to seek
care;
• Manage patients at home or at the outpatient level where possible
and safe to do so (see Table 1);
• Make every health service contact count: reinforce messaging on
behaviour change and hygiene measures for patients and their
caregivers;
• Adopt at a minimum distancing between people where possible,
universal usage of face coverings (especially where distancing between
people is not possible), good ventilation and basic IPC measures
(frequent hand hygiene and wearing of medical masks as appropriate)
[40] to minimise the risk of asymptomatic or pre-symptomatic spread;
• Triage all patients at all contact points, separating suspected COVID-19
cases from other patients [41], and adopt appropriate IPC measures
[42] for any contact with suspected COVID-19 patients (see text for
proposed scenarios of testing and separation). If triage and separation
measures are unfeasible or overwhelmed by caseload, ensure basic IPC
measures;
• Adopt patient cohorting and separation measures to minimise mixing
of COVID-19 and non COVID-19 patients (see text).
Healthcare workers:
• Ensure all healthcare workers adhere to IPC measures [42] for any
contact with patients, irrespective of patients’ signs and symptoms and
depending on level of exposure, and minimise physical contact
(without such adaptations compromising clinical effectiveness);
• Ensure all healthcare workers (including community health workers
and non-clinical staff) monitor themselves and household contacts and
immediately report COVID-19 symptoms. Staff should be supported to
stay away from work while they or a member of their household is un-
well. Where available and possible, they could be supported to stay
elsewhere if a member of the household unwell and they are well
(whilst still being required to isolate for the 14 day period);
• Prioritise SARS-CoV-2 testing for health care workers who are have
symptoms, so that they can return to work if negative (rather than self-
isolate), and to identify those who need to stay away from work if
positive.
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Fig. 2. Possible configuration of patient pathways and cohorting within a routine primary- or secondary-level facility during a period of high
SARS-CoV-2 transmission and in a setting with high background incidence of other diseases with similar symptoms
Table 3 Expected variation in positive predictive value (i.e. probability that a case meeting the diagnostic criteria is truly ill with
COVID-19) by COVID-19 incidence











Low Very high High
High Very high Low to moderate (for mild and moderate cases)
Moderate to high (for severe cases)
Medium
(just after or just before
the peak)
Low Very high Moderate to high








(early or late in the epidemic)
Low High Low to moderate (for mild and moderate cases)
Moderate to high (for severe cases)
High Moderate to high (depends
on test specificity)
Very low (for mild and moderate cases)
Low (for severe cases)
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Early triage and separation of patients with suspect
COVID-19 symptoms from others remains important at
both outpatient and inpatient level to reduce nosocomial
transmission, even under syndromic diagnosis. However,
this benefit could be negated if the COVID-19 patient
pathway results in crowding and increased physical con-
tact. In addition, syndromic diagnosis will miss asymp-
tomatic but infectious COVID-19 patients who are
attending for another reason. This highlights the import-
ance of maintaining very stringent IPC within all health-
care settings, including for example universal usage of
masks especially where it is not possible to maintain dis-
tancing between people [40].
Service monitoring and review
Resource allocation and service design should be con-
stantly re-evaluated in light of service utilisation and
outcomes, patient and community feedback and the evo-
lution of the epidemic itself. This requires real-time in-
formation on transmission in the community, health
service performance (Table 4 suggests key indicators),
and proactively elicited beneficiary feedback (e.g.
through focus group discussions). Generally, patient out-
come monitoring will be more difficult to interpret
where testing is insufficient.
If the quality and safety of care are compromised, e.g. by
high caseload pressure, inpatient COVID-19 services
should be stepped down to ensure there are adequate re-
sources for IPC and home / community care (see Table 1),
by cutting back on intensive care first. Clinical teams
should be supported to prioritise limited inpatient re-
sources for cases with the greatest chances of recovery.
Conclusion
Managing COVID-19 epidemics in fragile states and
crisis-affected populations presents an unprecedented
challenge for humanitarian actors, with huge competing
population needs and limited resources. The most mar-
ginalised and vulnerable populations are likely to be the
most affected. We have outlined some considerations for
planning COVID-19 treatment services with the aim of
holistically meeting population health priorities, support-
ing safe syndromic management strategies, and ration-
ally and equitably allocating resources to prevent
avoidable deaths, protect routine health services and en-
sure that services are appropriate and acceptable to the
local population. The COVID-19 challenge is unprece-
dented and rapidly evolving. Resource allocation and
service design must accordingly be reviewed continu-
ously, with immediate adaptations if warranted and
transparent dissemination of outcomes and experiences.
Table 4 Suggested key performance indicators for COVID-19 hospitalisation services. A weekly frequency of data collection and
review is recommended
Indicator Interpretation
Proportion of days with stock-out of an essential tracer medical item
(e.g. oxygen, intravenous fluids, key PPE items)
Indicates robustness of supply chain and consequent quality and safety
of care.
Average bed occupancy As well as resource utilisation, < 100% occupancy during a period of
known intense transmission may suggest barriers to access, including
community concerns about the care being offered.
Proportion of arriving patients who met criteria for admission but
were turned away or whose admission was delayed (by clinical status)
Indicates extent to which services meet demand.
Proportion of cases admitted, by age group and co-morbidity status May indicate whether specific groups of patients (e.g. the most elderly or
women) are not presenting for care: compare with what is expected
based on data from the rest of the country or the region.
Proportion of critical cases among patients admitted A high proportion of critical cases may indicate a delay in care-seeking.
Proportion of patients that become critical after admission Indicates quality of non-invasive respiratory support and associated care.
Compare with data from high-income settings.
Case-fatality ratio among non-critical patients Indicates quality of non-invasive respiratory support and associated care.
Compare with data from high-income settings.
Case-fatality ratio among critical patients Indicates quality of invasive respiratory support and associated care. Compare
with data from high-income settings. A high case-fatality ratio may also
indicate the extent to which ventilation is safe and beneficial.
Proportion of healthcare workers utilising appropriate PPE, by role Indicates availability, effectiveness of training, adherence to procedures
and understanding of risk.
Proportion of healthcare workers who become ill with test-confirmed
or syndromically diagnosed COVID-19
Indicates safety of care for healthcare workers. Compare with data from
high-income settings. A high risk of illness or death in healthcare workers
from COVID-19 could be a criterion for closing the facility.
Proportion of discharged patients who are happy with the care
received
Indicates quality and humanity of care.
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